Corcept Therapeutics | CORT - Ebitda

Stock Price
32.15
Daily Change
-0.24 -0.74%
Monthly
-18.87%
Yearly
-42.60%
Q1 Forecast
31.18

Corcept Therapeutics reported $4.2M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Acadia Pharmaceuticals USD 35.76M 447K Sep/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
ANI Pharmaceuticals USD 65.36M 5.76M Dec/2025
Ardelyx USD 5.57M 17.44M Sep/2025
Aurora Cannabis CAD 15.37M 26.8M Sep/2025
BioMarin Pharmaceutical USD -24.17M 18.91M Dec/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Canopy Growth CAD 16.62M 38.45M Sep/2025
Corcept Therapeutics USD 4.2M 6.5M Dec/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Esperion Therapeutics USD -27.51M 9.5M Sep/2023
J&J USD 9.52B 389M Sep/2025
Knight Therapeutics CAD 15.51M 3.39M Jun/2025
Merck USD 8.39B 1.97B Sep/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Novartis USD 5.88B 290M Sep/2025
Novartis USD 5.84B 235M Sep/2025
Omeros USD -47.96M 7.39M Sep/2023
Pacira USD 38.71M 10.65M Dec/2025
Pfizer USD 6.08B 351M Sep/2025
Supernus Pharmaceuticals USD 48.5M 6.6M Dec/2025
TG Therapeutics USD 32.69M 5M Sep/2025